,sentence,pubmed_id,content,label,labeler
0,37 ||| MATERIALS AND METHODS ||| 1.3 ||| Patients were eligible if 1) they were aged 18-70 yr; 2) they had ischemic chest pain for > 30 min; 3) they were admitted to hospital < 24 hr after the onset of chest pain; 4) electrocardiography (ECG) showed ST segment elevation > 1 mm in two consecutive leads in the limb leads or > 2 mm in the precordial leads; and 5) they could be enrolled in the study < 72 hr after successful revascularization (defined as residual stenosis < 30% of the infarct-related artery [IRA]).,24431901, aged 18-70 yr,po.Age,lingtaiwei
1,37 ||| MATERIALS AND METHODS ||| 1.3 ||| Patients were eligible if 1) they were aged 18-70 yr; 2) they had ischemic chest pain for > 30 min; 3) they were admitted to hospital < 24 hr after the onset of chest pain; 4) electrocardiography (ECG) showed ST segment elevation > 1 mm in two consecutive leads in the limb leads or > 2 mm in the precordial leads; and 5) they could be enrolled in the study < 72 hr after successful revascularization (defined as residual stenosis < 31% of the infarct-related artery [IRA]).,24431901,had ischemic chest pain for > 30 min,po.PhyConditon,lingtaiwei
2,37 ||| MATERIALS AND METHODS ||| 1.3 ||| Patients were eligible if 1) they were aged 18-70 yr; 2) they had ischemic chest pain for > 30 min; 3) they were admitted to hospital < 24 hr after the onset of chest pain; 4) electrocardiography (ECG) showed ST segment elevation > 1 mm in two consecutive leads in the limb leads or > 2 mm in the precordial leads; and 5) they could be enrolled in the study < 72 hr after successful revascularization (defined as residual stenosis < 32% of the infarct-related artery [IRA]).,24431901,were admitted to hospital < 24 hr after the onset of chest pain,po.Treatment,lingtaiwei
3,37 ||| MATERIALS AND METHODS ||| 1.3 ||| Patients were eligible if 1) they were aged 18-70 yr; 2) they had ischemic chest pain for > 30 min; 3) they were admitted to hospital < 24 hr after the onset of chest pain; 4) electrocardiography (ECG) showed ST segment elevation > 1 mm in two consecutive leads in the limb leads or > 2 mm in the precordial leads; and 5) they could be enrolled in the study < 72 hr after successful revascularization (defined as residual stenosis < 33% of the infarct-related artery [IRA]).,24431901, ST segment elevation > 1 mm in two consecutive leads in the limb leads or > 2 mm in the precordial leads,po.PhyConditon,lingtaiwei
4,96 ||| MATERIALS AND METHODS ||| 1.62 ||| Study hypothesis is to demonstrate the superiority of MSCs treatment compared with control group.,24431901, the superiority of MSCs treatment compared with control group,pr.Disease,lingtaiwei
5,4 |||  ||| 0.4 ||| Eighty patients with AMI after successful reperfusion therapy were randomly assigned and received an intracoronary administration of autologous BM-derived MSCs into the infarct related artery at 1 month.,24431901,Eighty patients,po.Size,lingtaiwei
6,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with cardiogenic shock,po.Disease,lingtaiwei
7,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with life-threatening arrhythmia,po.Disease,lingtaiwei
8,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with advanced renal or hepatic dysfunction,po.Disease,lingtaiwei
9,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with history of previous coronary artery bypass graft,po.Disease,lingtaiwei
10,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with history of hematologic disease and malignancy,po.Disease,lingtaiwei
11,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with major bleeding requiring blood transfusion,po.Disease,lingtaiwei
12,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with stroke or transient ischemic attack in the previous 6 months,po.Disease,lingtaiwei
13,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with use of corticosteroids or antibiotics during the previous month,po.Disease,lingtaiwei
14,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with major surgical procedure in the previous 3 months,po.Disease,lingtaiwei
15,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with cardiopulmonary resuscitation for > 10 min within the previous 2 weeks,po.Disease,lingtaiwei
16,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with positive skin test for penicillin,po.Disease,lingtaiwei
17,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,"excluded patients with positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test)",po.Disease,lingtaiwei
18,"38 ||| MATERIALS AND METHODS ||| 1.4 ||| We excluded patients with cardiogenic shock, life-threatening arrhythmia, advanced renal or hepatic dysfunction, history of previous coronary artery bypass graft, history of hematologic disease and malignancy, major bleeding requiring blood transfusion, stroke or transient ischemic attack in the previous 6 months, use of corticosteroids or antibiotics during the previous month, major surgical procedure in the previous 3 months, cardiopulmonary resuscitation for > 10 min within the previous 2 weeks, positive skin test for penicillin, positive result for viral markers (human immunodeficiency virus [HIV], hepatitis B virus [HBV], hepatitis C virus [HCV] and Venereal Disease Research Laboratory [VDRL] test), pregnant woman and possible candidate for pregnancy.",24431901,excluded patients with pregnant woman and possible candidate for pregnancy.,po.Disease,lingtaiwei
19,"42 ||| MATERIALS AND METHODS ||| 1.8 ||| Mononuclear cells were separated from the BM by density gradient centrifugation (HIS-TOPAQUE-1077; Sigma-Aldrich, St. Louis, MO, USA) and washed with phosphate-buffered saline (PBS).",24431901,Mononuclear cells were separated,i.Diagnostic,lingtaiwei
20,"42 ||| MATERIALS AND METHODS ||| 1.8 ||| Mononuclear cells were separated from the BM by density gradient centrifugation (HIS-TOPAQUE-1077; Sigma-Aldrich, St. Louis, MO, USA) and washed with phosphate-buffered saline (PBS).",24431901,washed with phosphate-buffered saline,i.Diagnostic,lingtaiwei
21,"189 ||| DISCUSSION ||| 4.41 ||| More patients in control group (5/36, 13.9%) were excluded than those in treatment group (1/33, 3.0%).",24431901,"More patients in control group (5/36, 13.9%) were excluded ",i.Diagnostic,lingtaiwei
22,152 ||| DISCUSSION ||| 4.4 ||| Our results met the primary endpoint of ≥ 4.3% improvement in LVEF compared with the control group.,24431901,≥ 4.3% improvement in LVEF compared with the control group,o.Patient,lingtaiwei
23,1 |||  ||| 0.1 ||| Recent studies suggest that the intracoronary administration of bone marrow (BM)-derived mesenchymal stem cells (MSCs) may improve left ventricular function in patients with acute myocardial infarction (AMI).,24431901,the intracoronary administration of bone marrow (BM)-derived mesenchymal stem cells (MSCs) may improve left ventricular function in patients with acute myocardial infarction (AMI),o.Treatment,lingtaiwei
